| Literature DB >> 33819902 |
Vinh Van Tran1, Nhu Hoa Thi Tran2, Hye Suk Hwang3, Mincheol Chang4.
Abstract
Rapid, accurate, portable, and large-scale diagnostic technologies for the detection of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) are crucial for controlling the coronavirus disease (COVID-19). The current standard technologies, i.e., reverse-transcription polymerase chain reaction, serological assays, and computed tomography (CT) exhibit practical limitations and challenges in case of massive and rapid testing. Biosensors, particularly electrochemical conducting polymer (CP)-based biosensors, are considered as potential alternatives owing to their large advantages such as high selectivity and sensitivity, rapid detection, low cost, simplicity, flexibility, long self-life, and ease of use. Therefore, CP-based biosensors can serve as multisensors, mobile biosensors, and wearable biosensors, facilitating the development of point-of-care (POC) systems and home-use biosensors for COVID-19 detection. However, the application of these biosensors for COVID-19 entails several challenges related to their degradation, low crystallinity, charge transport properties, and weak interaction with biomarkers. To overcome these problems, this study provides scientific evidence for the potential applications of CP-based electrochemical biosensors in COVID-19 detection based on their applications for the detection of various biomarkers such as DNA/RNA, proteins, whole viruses, and antigens. We then propose promising strategies for the development of CP-based electrochemical biosensors for COVID-19 detection.Entities:
Keywords: COVID-19; Conducting polymer; Electrochemical biosensor; Immuno-sensor; SARS-CoV-2
Year: 2021 PMID: 33819902 PMCID: PMC7992312 DOI: 10.1016/j.bios.2021.113192
Source DB: PubMed Journal: Biosens Bioelectron ISSN: 0956-5663 Impact factor: 10.618
Competitive advantages, applicability, and challenges of different techniques for COVID-19 detection.
| Diagnosis techniques | Point of use | Advantages | Disadvantages | Refs |
|---|---|---|---|---|
| Optical biosensors | Laboratories, hospitals, households | Safe, straightforward use, and cost-effective technology | Cannot completely replace other techniques such as RT-PCR or ELISA | ( |
| Photo thermal biosensors (Surface Plasmon Resonance biosensor) | Laboratories, hospitals, households | Possibility of real-time, rapid, and large-scale diagnosis of COVID-19 | Cannot completely replace other techniques such as RT-PCR or ELISA | ( |
| Electrochemical biosensors: CP-based biosensors | Laboratories, hospitals, households | Easy and cost-effective approach and a biocompatible method | Cannot completely replace other techniques such as RT-PCR or ELISA | ( |
| RT-PCR | Special laboratories and hospitals | The gold-standard diagnostics technique for SARS-CoV-2 infection | In the early stages of the COVID-19 outbreak, a significant rate of false -positive or -negative cases were detected | ( |
| CT scan | Special laboratories and hospitals | CT scans show high sensitivity (86–98%) | Low specificity to COVID-19 (25%) because of the overlapping imaging features with numerous other diseases | ( |
| ELISA and other serological assays | Special laboratories and hospitals | Qualitative or semi-quantitative results can be obtained with adequate sensitivity | To obtain the optimal accuracy, highly skilled personnel are required | ( |
Fig. 1Schematic summary of the main content of the study.
Fig. 2Schematic structure of SARS-Cov-2 and its biomarkers for diagnosis.
Summary of properties and detecting mechanisms of available biomarkers for detecting COVID-19 via electrochemical biosensors.
| Biomarkers | Properties | Recognition elements (probes) | Detecting mechanism | Refs |
|---|---|---|---|---|
| RNA | N gene gRNA | CRISPR-Cas12 Aptamer | Complementary interaction of genes | ( |
| Whole virus and Proteins | Receptor binding domain (RBD) | Antibody | Conformational recognition | ( |
| Antibody | IgM antibody | S proteins | Protein-antibody interaction | ( |
| Neutralizing antibodies: | The receptor-binding domain (RBD) | Inhibiting the interaction of RBD and human angiotensin-converting enzyme 2 (ACE-2) | ( |
Summary of preparation methods and properties of common conducting polymers in electrochemical biosensors.
| Polymers | Preparation | Properties | Refs |
|---|---|---|---|
| Polyacetylene | Emulsion polymerizations | Water insolubility and low solubility in organic solvents | ( |
| Electrochemical synthesis | Solubility in DMSO, chloroform, chlorobenzene, and tetrachloromethane | ( | |
| Electrochemical synthesis | Insolubility in ordinary solvents | ||
| Polymerization of quinodimethane intermediates | Water insolubility | ||
| Chemical oxidative polymerization | Insolubility in the common organic solvents, solubility in NMP, DMSO, DMF, and THF | ||
| UV-irradiation polymerization | Available aqueous dispersion | ( |
Fig. 3Schemes of immobilization strategies: (1) physical adsorption, (2) electrochemical entrapment, (3) covalent attachment.
Summary of the main properties, advantages, and drawbacks of immobilization techniques.
| Techniques | Properties | Advantages | Disadvantages | Refs |
|---|---|---|---|---|
| Physical adsorption | Exploiting the electrostatic interactions between the positively charged CP surface and negatively charged SARS-CoV-2 probes, as well as other interactions (hydrophobic, van der Waals forces) in the adsorption of antibodies and other proteins | No requirement of the functionalization to monomers and probes | Highly pH-dependent binding forces and a small number of attached recognition elements | ( |
| Covalent immobilization | Biomolecule probes are modified and functionalized by adding –NH2, –COOH, and other groups, and these probes are then covalently attached to functionalized monomers or CP polymers | Low diffusional resistance and high stability under stress | Decreased activity of biomolecules probes | ( |
| Electrochemical entrapment immobilization | This method relies on the electrochemical oxidation of a suitable monomer on the corresponding CPs via a solution containing SARS-CoV-2 probes | Straightforward and prolonged immobilization for molecular probes with several advantages such as its simplicity and reproducibility | Damage to probes (particularly DNA) due to the use of high potentials during the electrochemical polymerization | ( |
Fig. 4(a) Schematic illustration of the preparation process of antifouling RNA biosensors using peptides for surface modification of PANI polymer. Reproduced with permission from (Wang et al., 2020a); (b) Biosensor based on PEDOT grafted sialyllactose for human influenza A virus detection. Reproduced with permission from (Hai et al., 2017); (c) Functionalization of PEDOT for DNA biosensor using CuAAC reaction. Reproduced with permission from (Galán et al., 2015).
Fig. 5(a) CP nanostructures for electrochemical biosensors: (i) nanotubes (ii) nanowires and (iii) microspheres Reproduced with permission from (Xia et al., 2010); (b) Proposed approaches for the design of nanowire-based electrochemical biosensors. Reproduced with permission from (Travas-Sejdic et al., 2014); (c) Schematic illustration of PPy nanowires-based electrochemical biosensor for virus detection: (i) T7 antibody-functionalized PPy nanowire, (ii) BSA blocking, and (iii) virus phage interacts with probes on the nanowire surface. Reproduced with permission from (Shirale et al., 2010).
Fig. 6(a) Preparation process of PEDOT microspheres using ultrasonic spray polymerization, (b) SEM and TEM of three types of PEDOT microspheres: (i, ii) solid microspheres (iii, iv) porous microspheres, and (v, vi) hollow microsphere. Reproduced with permission from (Zhang and Suslick, 2015).
Fig. 7Fabrication process of the immuno-sensor based on porous PANI. Reproduced with permission from (Liu et al., 2018).
Summarized electrochemical biosensor applications of conducting polymer composites.
| Composites | Probe/biomarkers | Detecting range | LOD | Refs |
|---|---|---|---|---|
| PEDOT/CNT | Biotinylated aptamer/DNA | 1.0–1.0 × 108 fg/mL | 0.5 fg/mL | |
| PPy/CNT | ssDNA probe/DNA | 1.0 × 10−5–3.0 × 10−8 mol/L | 1.0 × 10−8 mol/L | |
| PPy/MWCNTs | ssDNA probe/DNA | 1 fM–100 nM | 0.3 fM | |
| PANI/graphene | ssDNA probe/DNA | 0.1 pM–1 μM | 0.01 pM | |
| PPy/graphene | Anti-VEGF RNA aptamer/RNA | – | 100 fM | |
| PPy/graphene | Adenine and Guanine | Adenine: 0.06–100 μM | 0.02 μM | |
| PEDOT:PS/RGO | ssDNA probes/DNA | 50 fM–2 μM | 17 fM | ( |
| PANI/GQDs | Antibody/Whole virus | 1 fg/mL–100 pg mL−1 | 0.8 fg/mL | |
| PANI/GO | Negative ssDNA/DNA | 1.0 × 10−15–1.0 × 10−8 mol/L | 2.5 × 10−16 mol/L | |
| PEDOT/AuNPs | ssDNA probes/DNA | 150 pM–1 μM | – | |
| PPy/AuNPs | ssRNA probe/RNA | 100 aM–1 nM | 78 aM | |
| PANI/AuNPs | Biotinylated DNA probe/ | 4–4 × 106 CFU | 4 CFU | |
| PEDOT/AuNPs | Antibody/disease biomarker | 0.001–1000 U/mL | 0.32 mU/mL | |
| PPy-PEDOT/AgNPs | ssDNA/DNA | 10−14–10−11 M | 5 × 10−15 M | |
| PPy/AgNF | PNA/miRNA-21 | 0.20 fM–1.0 nM | 0.2 fM | |
| PEDOT: PSS/Fe2O3 | Antibody/CEA protein | 4–25 ng/mL | – | |
| PPy/CeO2 | ssDNA/DNA | 1.0 nM–1 μM | 0.29 μM | |
| PANI/Ag–Cu | -/ | – | 108 CFU | |
| PANI/PAA | ssDNA probes/DNA | 5.0 × 10−8–2.0 × 10−7 M | 2 × 10−8 M | |
| PPy nanowire/PEG | DNA probe/RNA | 0.10 pM–1.0 nM | 0.033 pM | |
| PPy/PEDOT:PS | DNA/- | – | – | |
| PEDOT/PEG | Antibody/protein | 0.001–10 fg/mL | 0.0003 fg/mL | |
| PPy/PAA | ssDNA probe/DNA | 1–50 μM | 0.01 nM | |
Fig. 8Composites based on the integration of conducting polymer and carbon-based materials for COVID-19 electrochemical biosensors: (1) CPs and CNT composite; (2) CPs and MWCNT composite; (3) CPs and graphene composite; and (4) CPs and GO composite.
Fig. 9(a) Schematic illustration of an electrochemical biosensor based on PPy/AuNPs composite for RNA detection (b) Fabrication procedure of a label-free biosensor based on PPy/AgNF composite for RNA detection. Reproduced with permission from (Kangkamano et al., 2018); (c) Immuno-sensor based on Fe2O3-PEDOT composites for detecting pathogens. Reproduced with permission from (Kumar et al., 2019).
Fig. 10Schematic illustration of the preparation of a PEDOT/PEG conducting copolymer-based electrochemical biosensor for detecting protein. Reproduced with permission from (Cui et al., 2016).
Fig. 11(a) Preparation of a PANI/PA-based electrochemical biosensor with antifouling ability for miRNA detection. Reproduced with permission from (Yang et al. 2020b); (b) Patterning of pure PEDOT:PSS hydrogels: Free-standing pure PEDOT:PSS pattern and robust laminate of pure PEDOT:PSS hydrogel pattern. Reproduced with permission from (Lu et al., 2019).
Fig. 12(a) Flexible DNA biosensor based on the integration of PEDOT:PSS-based OECT and flexible microfluidic systems: (i) fabrication process, (ii) photographs of the bent. Reproduced with permission from (Lin et al., 2011); (b) Flexible biosensors for different bending radius during bending and relaxing. Reproduced with permission from (Kwon et al., 2013); (c) PAAm/PANI-based hydrogel as an electronic skin fixed on forefinger of a human hand (Duan et al., 2016); (d) Graphene-based biosensor device for detecting SARS-CoV-2. Reproduced with permission from (Seo et al., 2020b).